Your browser doesn't support javascript.
loading
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant.
Edara, Venkata-Viswanadh; Manning, Kelly E; Ellis, Madison; Lai, Lilin; Moore, Kathryn M; Foster, Stephanie L; Floyd, Katharine; Davis-Gardner, Meredith E; Mantus, Grace; Nyhoff, Lindsay E; Bechnak, Sarah; Alaaeddine, Ghina; Naji, Amal; Samaha, Hady; Lee, Matthew; Bristow, Laurel; Gagne, Matthew; Roberts-Torres, Jesmine; Henry, Amy R; Godbole, Sucheta; Grakoui, Arash; Saxton, Marybeth; Piantadosi, Anne; Waggoner, Jesse J; Douek, Daniel C; Rouphael, Nadine; Wrammert, Jens; Suthar, Mehul S.
Afiliação
  • Edara VV; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Manning KE; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Ellis M; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Lai L; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Moore KM; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Foster SL; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Floyd K; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Davis-Gardner ME; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Mantus G; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Nyhoff LE; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Bechnak S; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Alaaeddine G; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Naji A; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Samaha H; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Lee M; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Bristow L; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Gagne M; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Roberts-Torres J; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Henry AR; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Godbole S; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Grakoui A; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Saxton M; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Piantadosi A; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Waggoner JJ; Yerkes National Primate Research Center, Atlanta, GA, USA.
  • Douek DC; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
  • Rouphael N; Emory Vaccine Center, Emory University, Atlanta, GA, USA.
  • Wrammert J; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Suthar MS; Center for Childhood Infections and Vaccines of Children's Healthcare of Atlanta, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Cell Rep Med ; 3(2): 100529, 2022 02 15.
Article em En | MEDLINE | ID: mdl-35233550

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Vacina BNT162 / Vacina de mRNA-1273 contra 2019-nCoV / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinação / Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Vacina BNT162 / Vacina de mRNA-1273 contra 2019-nCoV / Anticorpos Antivirais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos